VKTX
Price
$24.22
Change
-$1.46 (-5.69%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
2.72B
19 days until earnings call
XLO
Price
$0.71
Change
-$0.02 (-2.74%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
37.86M
33 days until earnings call
Ad is loading...

VKTX vs XLO

Header iconVKTX vs XLO Comparison
Open Charts VKTX vs XLOBanner chart's image
Viking Therapeutics
Price$24.22
Change-$1.46 (-5.69%)
Volume$49.74K
Capitalization2.72B
Xilio Therapeutics
Price$0.71
Change-$0.02 (-2.74%)
Volume$1.6K
Capitalization37.86M
VKTX vs XLO Comparison Chart
Loading...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VKTX vs. XLO commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VKTX is a Hold and XLO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (VKTX: $25.68 vs. XLO: $0.73)
Brand notoriety: VKTX and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VKTX: 99% vs. XLO: 5%
Market capitalization -- VKTX: $2.72B vs. XLO: $37.86M
VKTX [@Biotechnology] is valued at $2.72B. XLO’s [@Biotechnology] market capitalization is $37.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VKTX’s FA Score shows that 0 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • VKTX’s FA Score: 0 green, 5 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, both VKTX and XLO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VKTX’s TA Score shows that 4 TA indicator(s) are bullish while XLO’s TA Score has 4 bullish TA indicator(s).

  • VKTX’s TA Score: 4 bullish, 3 bearish.
  • XLO’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than XLO.

Price Growth

VKTX (@Biotechnology) experienced а -2.51% price change this week, while XLO (@Biotechnology) price change was -0.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

VKTX is expected to report earnings on Apr 23, 2025.

XLO is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($2.72B) has a higher market cap than XLO($37.9M). XLO YTD gains are higher at: -26.681 vs. VKTX (-39.811). XLO has higher annual earnings (EBITDA): -58M vs. VKTX (-150.58M). VKTX has more cash in the bank: 903M vs. XLO (55.3M). VKTX has less debt than XLO: VKTX (1.12M) vs XLO (8.14M). XLO has higher revenues than VKTX: XLO (6.34M) vs VKTX (0).
VKTXXLOVKTX / XLO
Capitalization2.72B37.9M7,174%
EBITDA-150.58M-58M260%
Gain YTD-39.811-26.681149%
P/E RatioN/AN/A-
Revenue06.34M-
Total Cash903M55.3M1,633%
Total Debt1.12M8.14M14%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VKTXXLO
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 18 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSMVX10.87N/A
N/A
Principal SmallCap Value II R6
RTDRX14.73N/A
N/A
Russell Inv Multifactor US Equity R6
WMBLX13.03N/A
N/A
WesMark Balanced
IAUYX26.56N/A
N/A
Invesco Dividend Income Y
RERAX50.67-1.47
-2.82%
American Funds Europacific Growth R1

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with KRYS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-5.69%
KRYS - VKTX
40%
Loosely correlated
-1.58%
GPCR - VKTX
38%
Loosely correlated
-3.48%
ALT - VKTX
38%
Loosely correlated
-6.69%
CRNX - VKTX
38%
Loosely correlated
-8.03%
MREO - VKTX
38%
Loosely correlated
-6.75%
More

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and CRMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-4.24%
CRMD - XLO
31%
Poorly correlated
-3.17%
AXON - XLO
31%
Poorly correlated
-3.35%
VKTX - XLO
30%
Poorly correlated
-5.69%
VTGN - XLO
27%
Poorly correlated
-4.60%
AVTX - XLO
27%
Poorly correlated
-5.51%
More